We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+3.93%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.7B
AUM Growth
+$64.4M
Cap. Flow
-$22M
Cap. Flow %
-0.82%
Top 10 Hldgs %
23.88%
Holding
495
New
21
Increased
128
Reduced
183
Closed
21

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$20.2M
2
MET icon
MetLife
MET
+$3.03M
3
BA icon
Boeing
BA
+$2.24M
4
IBM icon
IBM
IBM
+$2.05M
5
TIF
Tiffany & Co.
TIF
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 16.01%
2 Financials 13.43%
3 Industrials 11.95%
4 Technology 11.34%
5 Consumer Staples 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.51T
$25.4M 0.94%
148,490
-970
-0.6% -$162K
ABT icon
27
Abbott
ABT
$180B
$25.1M 0.93%
469,877
-5,022
-1% -$252K
DD icon
28
DuPont de Nemours
DD
$18.6B
$24.7M 0.92%
140,699
+123,187
+703% +$20.6M
MRK icon
29
Merck
MRK
$324B
$24M 0.89%
392,307
+640
+0.2% +$38.8K
MMM icon
30
3M
MMM
$89B
$23.7M 0.88%
135,265
-375
-0.3% -$65K
KO icon
31
Coca-Cola
KO
$354B
$23.3M 0.87%
518,555
-19,121
-4% -$870K
KHC icon
32
Kraft Heinz
KHC
$30.4B
$22.8M 0.85%
293,844
-1,483
-0.5% -$124K
MA icon
33
Mastercard
MA
$477B
$21.9M 0.81%
155,442
-1,581
-1% -$209K
NVS icon
34
Novartis
NVS
$295B
$21.7M 0.81%
282,448
-6,337
-2% -$479K
BRK.B icon
35
Berkshire Hathaway Class B
BRK.B
$1.07T
$21.6M 0.8%
117,627
+175
+0.1% +$30.9K
MDLZ icon
36
Mondelez International
MDLZ
$77.7B
$21.5M 0.8%
528,363
+2,183
+0.4% +$92.7K
VZ icon
37
Verizon
VZ
$194B
$20.9M 0.78%
422,196
-7,548
-2% -$355K
UN
38
DELISTED
Unilever NV New York Registry Shares
UN
$20M 0.74%
338,488
-2,724
-0.8% -$159K
GILD icon
39
Gilead Sciences
GILD
$161B
$19.7M 0.73%
243,048
-15,748
-6% -$1.2M
C icon
40
Citigroup
C
$222B
$19.7M 0.73%
270,307
+1,465
+0.5% +$100K
GOOGL icon
41
Alphabet (Google) Class A
GOOGL
$3.91T
$19.4M 0.72%
399,440
-8,940
-2% -$424K
MET icon
42
MetLife
MET
$61B
$19.2M 0.71%
370,440
-62,121
-14% -$3.03M
WFC icon
43
Wells Fargo
WFC
$261B
$19M 0.7%
343,913
-27,159
-7% -$1.44M
ZTS icon
44
Zoetis
ZTS
$31.6B
$18.3M 0.68%
287,354
-1,995
-0.7% -$125K
AGN
45
DELISTED
Allergan plc
AGN
$18M 0.67%
87,764
+4,729
+6% +$1.1M
NKE icon
46
Nike
NKE
$61.9B
$17.7M 0.66%
341,174
-8,352
-2% -$469K
AVGO icon
47
Broadcom
AVGO
$1.82T
$17.6M 0.65%
726,080
+11,040
+2% +$273K
PM icon
48
Philip Morris
PM
$301B
$17.5M 0.65%
158,058
-172
-0.1% -$20K
DHR icon
49
Danaher
DHR
$135B
$17.4M 0.65%
229,064
+4,944
+2% +$366K
ABBV icon
50
AbbVie
ABBV
$458B
$17.3M 0.64%
195,098
-8,735
-4% -$665K

Similar funds

Gofen & Glossberg's Q3 2017 Portfolio in Review

As of Q3 2017, Gofen & Glossberg held 495 positions worth $2.7B, up 2.4% from $2.63B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q3 2017 filing shows 21 new, 128 increased, 183 reduced and 21 closed positions. Its largest new stake was Brighthouse Financial: 19,111 shares worth $1.16M. The largest sale was Du Pont De Nemours E I, an estimated $20.2M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

  • Gofen & Glossberg's largest Q3 2017 buy was Brighthouse Financial: 19,111 shares worth $1.16M.
  • Gofen & Glossberg added most to DuPont de Nemours in Q3 2017, an estimated $20.6M increase.
  • Gofen & Glossberg's biggest Q3 2017 reduction was MetLife, cutting an estimated $3.03M.
  • Gofen & Glossberg fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $20.2M.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.7B portfolio in Q3 2017.
  • Gofen & Glossberg opened 21 new positions and closed 21 in Q3 2017.
  • Gofen & Glossberg's portfolio value rose 2.4% quarter-over-quarter to $2.7B.

Based on Gofen & Glossberg's 13F filing for Q3 2017, filed 16 Nov 2017.